We are live on
!
Find out more
EMR
Errol M. Rudman Portfolio holdings
AUM
$148M
1-Year Est. Return
19.65%
This Fund
S&P 500
This Quarter
Est. Return
+6.11%
1 Year Est. Return
+19.65%
3 Year Est. Return
+60.53%
5 Year Est. Return
+120.34%
10 Year Est. Return
–
AUM
$296M
AUM Growth
+$7.52M
(+2.6%)
Cap. Flow
-$2.5M
Cap. Flow
% of AUM
-0.84%
Top 10 Holdings %
Top 10 Hldgs %
46.87%
Holding
45
New
2
Increased
6
Reduced
5
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CBPO
China Biologic Products Holdings, Inc.
CBPO
|
+$2.1M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
+$1.43M |
| 3 |
ManpowerGroup
MAN
|
+$1.12M |
| 4 |
WOOF
VCA Inc.
WOOF
|
+$1.06M |
| 5 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PTX
Pernix Therapeutics Holdings, Inc.
PTX
|
+$3.99M |
| 2 |
MSO
MARTHA STEWART LIVING OMNIMEDIA INC
MSO
|
+$3.74M |
| 3 |
La-Z-Boy
LZB
|
+$1.35M |
| 4 |
CO
Global Cord Blood Corporation
CO
|
+$878K |
| 5 |
Bruker
BRKR
|
+$808K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.59% |
| 2 | Industrials | 25.27% |
| 3 | Financials | 9.83% |
| 4 | Technology | 9.29% |
| 5 | Consumer Discretionary | 8.7% |
Similar funds
HAM
TAM
RMPT
QAM
CWM
RCA
CI
LS
Errol M. Rudman's Q2 2015 Portfolio in Review
As of Q2 2015, Errol M. Rudman held 45 positions worth $296M, up 2.6% from $289M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Errol M. Rudman's Q2 2015 filing shows 2 new, 6 increased, 5 reduced and 1 closed positions. Its largest new stake was Patterson Companies, Inc.: 30,000 shares worth $1.46M. The largest sale was Pernix Therapeutics Holdings, Inc., an estimated $3.99M.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Industrials and Financials.
- Errol M. Rudman's largest Q2 2015 buy was Patterson Companies, Inc.: 30,000 shares worth $1.46M.
- Errol M. Rudman added most to China Biologic Products Holdings, Inc. in Q2 2015, an estimated $2.1M increase.
- Errol M. Rudman's biggest Q2 2015 reduction was Pernix Therapeutics Holdings, Inc., cutting an estimated $3.99M.
- Errol M. Rudman fully exited Global Cord Blood Corporation in Q2 2015, selling an estimated $878K.
- Errol M. Rudman's ten largest holdings make up 47% of its $296M portfolio in Q2 2015.
- Errol M. Rudman opened 2 new positions and closed 1 in Q2 2015.
- Errol M. Rudman's portfolio value rose 2.6% quarter-over-quarter to $296M.
Based on Errol M. Rudman's 13F filing for Q2 2015, filed 14 Aug 2015.